Steven Laureys：我从小就知道我会成为一名医生，然后我选择了神经科，因为这是我们理解最少的领 域——大脑的运作机制。大脑是宇宙中最复杂的物体。青少年时代我就在思考我们如何解释外部宇宙， 所以我很高兴现在能继续这份热情，那就是理解科学最大的谜团之一：我们的思想、感知和情感。这个 过程中，对于我来说很难说有某个决定性的时刻或者触发点。 作为一名在重症监护室工作的神经科医生，面对昏迷患者，我确实感到挫败。有很多患者让我感到不 安，我们之前经常说他们是无意识的，但意识是一种个人的、主观的体验。我很快意识到，我们的临床 能力非常有限，无法测量他们是否能感受到疼痛或愉悦，是否能听到母亲的声音。 当生命悬于意识的边缘，科学与伦理的边界变得模糊。 三十年来，比利时神经学家史蒂文·洛雷（Steven Laureys）教授始终站在这个交叉点上。Steven Laureys 作为欧洲科学院院士、比利时皇家科学院院士、国际意识研究学会（ASSC）主席、昏迷和意识障碍全 球联盟和欧洲联盟发起人和主席，还担任国际脑损伤协会和人类脑计划的委员和发言人。他同时也是是 国际上意识障碍领域最具影响力的比利时昏迷科学团队的创始人，担任 ...

有投资者在互动平台向北陆药业提问："医未医疗是国内唯一覆盖脑部疾病'筛查-诊断-康复'全流程的脑 科学AI企业，技术路径为非侵入式脑机接口+神经调控+医疗AI，聚焦卒中、AD、认知障碍等刚需场 景。请问贵公司目前持有医未医疗多少股份？医未医疗是否考虑IPO？谢谢。" 声明：市场有风险，投资需谨慎。本文为AI基于第三方数据生成，仅供参考，不构成个人投资建议。 来源：市场资讯 针对上述提问，北陆药业回应称："感谢您的关注。目前公司持有医未医疗14.9881%的股份，系其第二 大股东。" ...

Core Insights - Integer Holdings has appointed Payman Khales as the new CEO, succeeding Joseph Dziedzic who retired after eight years [2] - The company reported Q3 2025 sales revenue of $468 million, an 8% year-over-year increase, with adjusted earnings per share growing by 25% [3] - Integer's strategic focus is shifting from a manufacturing-centric model to a customer-centric innovation platform [11][12] Leadership Transition - Payman Khales joined Integer in 2018 and previously served as the president of the Cardio & Vascular Business, where he successfully doubled sales over seven years [6] - Khales has a strong background in industrial manufacturing and operations management, having held senior positions at CECO Environmental Corp. and Ingersoll Rand Co. [7] - His vision for Integer emphasizes innovation and collaboration with customers to enhance clinical value in medical technology [7] Business Structure and Global Positioning - Integer operates as a leading Contract Development and Manufacturing Organization (CDMO), providing end-to-end services from product design to supply chain integration [9] - The company has two main business segments: Cardio & Vascular, which is the largest revenue contributor, and Advanced Surgical & Power Solutions, focusing on neuromodulation and implantable battery systems [9][10] - Integer has over 30 manufacturing and R&D centers globally, enhancing its supply chain stability and compliance management [10] Strategic Intent and Industry Impact - The leadership change signifies a strategic restructuring in response to the competitive landscape of the global CDMO market [11] - Integer aims to extend its capabilities from manufacturing to early product development and engineering validation, leveraging a "customer co-innovation" model [12] - The global medical device industry is experiencing a shift towards outsourcing non-core manufacturing to CDMO partners, with the market expected to grow from approximately $15 billion in 2023 to $27 billion by 2030 [13] Future Directions - Under Khales, Integer is likely to enhance investments in digital manufacturing, supply chain transparency, and sustainable operations, aligning with industry trends [13] - The transition positions Integer to evolve from a traditional contract manufacturer to a high-end medical manufacturing platform with innovation incubation capabilities [14] - The leadership change reflects broader structural changes in the medical device manufacturing sector, where OEMs and CDMOs are increasingly collaborating in design and innovation processes [14][15]

Group 1 - The event "2025 New Generation Talks" held in Hangzhou focused on the theme "Intelligent Creation of the Future: New Opportunities for Young Entrepreneurs in the AI Era," attracting over 300 young entrepreneurs to discuss development paths under the AI wave [2] - Wu Haiyu, Vice Chairman of the Zhejiang Provincial Federation of Industry and Commerce, emphasized that AI is a young industry and young entrepreneurs should seize development opportunities while taking on responsibilities [2] - Zhejiang is positioning itself as a leader in the digital economy, actively building an AI industry ecosystem to provide a broad innovation platform for young entrepreneurs [2] Group 2 - Chen Bin, Chairman of Zhejiang Saizhi Bole Equity Investment Management Co., shared his investment philosophy of "investing early, investing small, investing in technology, and investing in quality," highlighting a significant increase in the valuation of one invested AI company from under 200 million to over 4 billion since 2021 [3] - The AI industry is categorized into three types: chip layer enterprises, middle layer enterprises focusing on computing power scheduling and data collection, and application layer enterprises related to vertical industries and AI tools [3] - Bian Wenyin, Director of Strategic Relations at Zhejiang Qiangnao Technology Co., introduced brain-computer interface technology and the company's focus on rehabilitation health, with plans to expand applications in various fields such as human-computer interaction and education [3] Group 3 - The "New Generation Talks" initiative aims to create a multi-dimensional interactive platform to promote collaboration among young entrepreneurs in thought exchange and industry cooperation [3]